Alexza Pharma (NASDAQ: ALXA) Alexza engages in the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions worldwide. Its product candidates are based on a proprietary technology, the Staccato system, which vaporizes…
Tag: pharma
Near Term Catalysts For Anacor Pharma Should Make For Nice Upside Gain
Trading biophama companies before a catalyst event, if done correctly, can be a very profitable proposition. Some traders and investors who enjoy bringing more risk into play often times will hold through the actual catalyst event. While this does bring…
Small Cap Bio-Pharmas For Possible Long Side Trades
With some added confidence shown by investors yesterday, it’s a good time to look at some “risk on” small cap bio-pharma stocks that I feel offer good upside for both swing trades and longer term holds. However, with the looming…
Amicus Therapeutics Should See a Big Upside Move On Positive Phase 3 Data
One company that has really received a ton of attention lately has been Sarepta Therapeutics (SRPT). Only a few weeks ago, the stock was trading in the $3 to $4 range. On 10/3/12, the company announced that it received positive…
